CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US12651E1064
CTT PHARMACEUTICAL HOLDINGS, INC. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 USD | 0.00 USD |
| Gross profit | -6,398.00 USD | -6,432.00 USD |
| Operating income | -250,000.00 USD | -126,770.00 USD |
| Net income | -210,000.00 USD | -155,907.00 USD |
Full history since 1999, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About CTT PHARMACEUTICAL HOLDINGS, INC.
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.
More stocks
- Vemanti Group, Inc. (VMNT)
- BASANITE, INC. (BASA)
- Longeveron Inc. (LGVN)
- SPARTA COMMERCIAL SERVICES, INC. (SRCO)
- Senti Biosciences Holdings, Inc. (SNTI)
- AIRWA INC. (YYAI)
- Knightscope, Inc. (KSCP)
- Global Warming Solutions, Inc. (GWSO)
- MANGOCEUTICALS, INC. (MGRX)
- Strive, Inc. (ASST)
- Wenyuan Group Corp. (WYGC)
- CXApp Inc. (CXAI)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.